Rare & Serious Diseases
Our top priority is saving and improving the lives of our patients. ORYX's commitment to enhancing the quality of life for people with rare and serious diseases in Bangladesh is reflected in our support of programs and activities for patients with rare plasma-protein related diseases, including bleeding disorders and primary immune deficiencies. We aim to improve and expand educational and outreach efforts. Through partnerships, we strive to raise public awareness and to enhance appropriate public policies for rare diseases.
Plasma Derived Product
Biotherapy products differ from conventional chemical-based pharmaceuticals in that they derive from human blood plasma or are manufactured using recombinant technologies.
Oryx Bio-Tech Bangladesh is proud to serve communities of people who have von Willebrand disease(VWD), hemophilia, primary immunodeficiency(PID), hereditary angioedema(HAE), fibrinogen deficiency, and other rare diseases.